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Abstract
Objectives Few studies have estimated the effect of
diabetes integrated care at a population level. We have
assessed the impact of introducing a community serviceled diabetes integrated care programme on commissioner
payments (tariff) for inpatient care in rural England.
Methods The Diabetes Integrated Care Initiative was
delivered by a separate enhanced community diabetes
service, increasing specialist nursing, dietetic, podiatry and
medical support to primary care and patients, while linking
into other diabetes specialist services. Commissioner data
were provided by the local authority. The difference in
area between the two overlapping distribution curves of
inpatient payments at baseline and follow-up (at 3 years)
was used to estimate the effect of integrated care on
commissioner inpatient payments on a population level.
Results Over the 3-year period, reduced inpatient
payments occurred in 2.7% (1.3% to 5.8%) of patients
with diabetes aged more than 70 years in the intervention
area. However, reduced diabetes inpatient payments
occurred in 3.20% (1.77% to 7.20%) of patients aged <70
years and 4.1% (2.3% to 7.9%) of patients ≥70 years in
one of the two adjacent areas.
Conclusion This enhanced community diabetes services
was not associated with substantially reduced inpatient
payments. Alternative diabetes integrated care approaches
(eg, with direct primary and secondary care collaboration
rather than with a community service) should be tested.

Introduction
As the social and economic impact of diabetes
grows, so does the variety of attempts to
improve care quality and reduce healthcare
costs among those affected.1–4 One approach,
which is able to provide at least equivalent care
to routine medical care with some types of
patients, has been the introduction of nurses
working within protocols, within medical
services.5 Other models known as ‘intermediate care’, including general practitioners

Strengths and limitations of this study
►► The ‘health gain’ in the revised method was clearly

defined with a formulated algorithm of evaluation,
which broadened the utilisation scenarios especially
when negative values were raised.
►► The data used in this study depended on the
completeness of the coding for diabetes in the
general practitioner records. The impact of this
potential ascertainment bias should have been
steady as no systematic change in coding was
known to have occurred over this time period.
►► Data on some important confounders such as lipid
profiles were not available in this study.

with a special interest,6 and community
diabetes nursing services6 have been implemented, but without robust evaluation. As a
proposed system, integrated care articulates
all health workers and health systems around
the needs of each patient and should be associated with improved outcomes and less cost.7
However, the impact of a population-based
integrated care intervention is difficult
to measure on an individual level. One
randomised trial of an intermediate care
service achieved minimal actual incremental benefit.8 By their nature, randomised
controlled trials are difficult to use when
assessing the impact of a complete system
change at a population level. Sarkadi et al
have proposed a method to look at population outcomes in their own right in the quest
of understanding how interventions work
at a population level.9 Under the English
National Health Service (NHS), public inpatient care is paid for from taxation through
local commissioners. These payments do not
generally cover the hospital costs of inpatients
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with diabetes,10 but can provide an NHS commissioner
perspective that reflects both acuity and complexity,
beyond, for example, length of stay. We have now used
the Sarkadi approach to assess whether any changes in
population-based commissioner inpatient payment data
occurred during a diabetes integrated care intervention
by viewing the level and distribution of commissioner
inpatient payments in the population as the unit of
interest.
Methods
East Cambridgeshire and Fenland (ECF: 2009 population
160 000, diabetes population 7790) is largely rural, with
a small number of socioeconomically deprived communities.6 There is no local major hospital (with, eg, an
emergency department) falling within the catchment
areas of four hospitals outside of the area. Some diabetes
outcomes have been historically poor.11 A separate, local,
diabetes specialist nurse-led community service was introduced in 2003.12 From April 2009, this was replaced with
a new Diabetes Integrated Care Initiative (DICI) using
additional finance (£250 000 pa), in an attempt to address
continuing health disparities. The components of the
DICI have been described in the previous publications.13
The health district includes two other areas, Huntingdonshire and Greater Cambridge, which did not receive the
full intermediate team and are able to serve as ‘control’
areas, although each hospital-based service would have
continued with its own internal service developments. We
have previously reported no impact on metabolic control
or hospitalisation rates in spite of full implementation of
the service.6
Deidentified electronic Secondary Uses Service data
for across Cambridgeshire were obtained for recorded
inpatient tariff between April 2007 (ie, 2 years before
the DICI contract commenced) and March 2012. Practice, patient age, elective/non-elective status,International Classification of Diseases 10th revision (ICD10)
and Health Related Group coding were included in the
dataset. Diabetes was considered present if E10– E14 was
in any ICD10 field and, as the primary cause of admission if coded in the first field.14 15 Inpatient payments
recorded in 2008–2009 were used as baseline, to compare
with that recorded in 2011–2012 as the end of the intervention period. Using the Sarkadi et al method, the
mean and SD for normal distributions before and after
the intervention can be estimated. The ‘health gain’
is defined as the area between the two distribution
curves on the right side, where the distribution density
after intervention is lower (the shaded area in online
supplementary figure 1 left). In our study, ‘health gain’
represents the proportion of patients with reduced inpatient payments between the baseline and intervention
period. The reduction in commissioner payments reflects
reduced needs in care and thus improvement in health.
Sarkadi’s method has outlined ways to calculate the
impact when the two distributions have the same SD, or
2

when the follow-up group has smaller mean and smaller
SD at the same time. However, we have noticed when
using real data that the follow-up group might have
smaller mean but larger SD To accommodate this situation; we have modified the Sarkadi’s method as described
in online supplementary technical appendix and online
supplementary figure 1. The health gain distributions are
presented in online supplementary figure 2 to illustrate
the health gains at a population level.
In addition to the normal distribution originally used
in Sarkadi’s method, three other distributions, gamma
distribution, log-normal distribution and normal distribution of log-transferred payment data, were attempted
to fit the data. The goodness-of-fit statistics, Akaike information criterion (AIC), Bayesian information criterion
(BIC) and log-likelihood were tested over four distributions and the distribution with the minimum AIC, BIC
and maximum log-likelihood was chosen as the final
distribution to examine the impact.
Bootstrapping is used to obtain a P value for the probability of health gain larger than zero. We randomly
sampled data points with replacements from the original
data separately for the baseline and follow-up, so that
we obtain bootstrapped data with the same numbers of
data points. These are used to obtain an estimation of the
health gain after perturbation. This process is repeated
1000 times. The probability of observing estimations
less than or equal to zero is calculated, and used as the
approximation of the P value for testing whether health
gain is significantly larger than zero.
No personal identifiers were released to researchers,
and all subsequent analyses were conducted on anonymised datasets. Age data were provided allowing analyses
to be undertaken above and below the median age (70
years) to assess any related variation.
The work had approval from the Cambridgeshire
research ethics committee as part of a wider service evaluation and, as such, was deemed not to require personal
informed consent.
All analyses were conducted in R (V.3.1).
Results
The sample size of inpatient payment records during the
baseline and the intervention periods in each region is
presented in table 1. The inpatient payments during the
baseline period and the intervention period are shown
in table 2 by area and age group. In each area and age
group, a lower individual median inpatient payment was
more likely to be found in the intervention period.
Figure 1 shows the distribution of the inpatient
payments in people with type 2 diabetes in the baseline
and intervention periods. This illustrates the effect of the
integrated care intervention, as the left-moving curve in
the intervention period indicates the potential inpatient
payment saving at a population level.
Four distributions (normal distribution, gamma
distribution, log-normal distribution and normal
Yu D, et al. BMJ Open 2017;7:e015816. doi:10.1136/bmjopen-2017-015816
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Table 1 Sample size of the inpatient payment records

2008–2009
2011–2012

East Cambridge and Fenland

Huntingdonshire

<70 years

≥70 years

<70 years

≥70 years

<70 years

≥70 years

2012
2431

2028
2756

1494
1871

1664
1990

1575
2004

1329
1823

distribution of log-transformed payment data) were
attempted to fit the payment data as presented in online
supplementary table 1. The normal distribution of
log-transformed payment data was chosen to estimate the
impact on the intervention for its minimum AIC and BIC
and its maximum log-likelihood.
The magnitude of the intervention at the population
level is presented in table 3. Significant ‘health gain’
was observed both in the intervention area and control
areas, especially among patients aged less than 70 years.
In the intervention area, East Cambridge and Fenland,
7.69% (95 CI 5.89% to 9.74%) and 2.05% (0.72% to
4.13%) of patients aged less than 70 years and aged
more than 70 years, respectively, had a reduced inpatient
payment, compared with the population in the baseline
period. In Huntingdonshire, the ‘health gain’ was 6.90%
(5.63% to 8.68%) and 4.62% (2.22% to 7.23%) among
patients aged less than 70 years and patients aged more
than 70 years, respectively. In Greater Cambridge, the
‘health gain’ was 7.59% (5.63% to 9.94%) and 2.49%
(1.46% to 4.58%) among patients aged less than 70 years
and patients aged more than 70 years, respectively.
To allow comparisons, the estimated impact, based on
a normal distribution, is presented in online supplementary table 2. In the intervention area, East Cambridge and
Fenland, 2.74% (1.29% to 5.81%) of patients aged more
than 70 years had a reduced inpatient payment, compared
with the population in the baseline period. In one of the
control areas, Greater Cambridge, ‘health gain’ was also
observed in 3.20% (1.77% to 7.20) of patients aged less
than 70 years and 4.14% (2.27% to 7.86) patients aged
more than 70 years, respectively. Significant ‘health gain’
was not identified within the population in Huntingdonshire over the study period.
Discussion
We have used a novel way, calculating the total health gain
(proportion of people with reduced inpatient payments)
assuming a Gaussian distribution, to assess the results
of integrated care in the diabetic population of areas in
Cambridgeshire through a population lens. The study
revealed a possible effect of the new integrated care
approach on inpatient payments, as 7.7% of patients aged
less than 70 years and 2.1% of patients aged more than 70
years had reduced inpatient payments in the intervention
area, East Cambridge and Fenland. However, reductions
were also seen in the control areas, in Huntingdonshire,
6.9% of patients aged less than 70 years and 4.6% of
patients aged less than 70 years had reduced inpatient
Yu D, et al. BMJ Open 2017;7:e015816. doi:10.1136/bmjopen-2017-015816

Great Cambridge

payment; in Greater Cambridge, 7.6% of patients aged
less than 70 years and 2.5% of patients aged less than 70
years had reduced inpatient. The 95% CIs overlapped
across the three areas, so we have not shown any differences between the areas.
Significant improvements in diabetes care can occur
with multifaceted interventions16 including disease
management in the USA17 and integrated care in
Germany,18 and these can be associated with reductions
in hospital costs.19 The integrated care intervention was
successfully implemented across the area, with positive
patient experience, improved practice nurse clinical
confidence and early reports of clinical benefit.13 20 It
is therefore surprising that although some (small) positive benefit was observed in the intervention area, the
return on the investment of £250 000 was not greater and
possibly less than in one of the control areas. Elsewhere,
diabetes integrated care interventions have generally
been more effective within single providers or in contexts
where multiple primary care organisations work with a
single specialist provider under an integrated insurance
scheme.6 The integrated care intervention carried out
in ECF followed a nurse-led service with one of the goals
reducing referrals (ie, payments) to hospital outpatients.
This philosophy, rather than progressing to truly integrated services, carried through the intervention period,
although as part of a wider programme that included
‘vertical integration’ developments. It was perhaps to be
expected that attempts at creating such greater ‘vertical’
integration in information management, clinical governance, budget and overall management were agreed, but
not implemented, actions more achievable within a single
organisation. There was an attempt to create a single
equal partner network model21 nearing the end of the
intervention period, but this was not funded by the local
commissioners.
The failure to implement integrated information
management almost certainly contributed to communication and integration difficulties. Most integrated care
initiatives attempt to include data sharing22 and this was
not possible within the local information governance
arrangements. This was noticed by the patients and was
a source of frustration. Interestingly, integration was
perceived as happening when there was one person
‘fronting up’ for all those involved. Case management
has been proposed as one approach to integration, and
requires the case manager to corral and coordinate the
services for a given individual.17
3
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79 (75–84)
1031 (611–2508)
59 (50–66)
781 (505–1688)
77 (73–83)
808 (469–2220)
60 (48–66)
677 (502–1666)
The median (IQR) was presented for both age and inpatient payment.

78 (74–83)
823 (498–2475)
Age, year
Inpatient payment, £
2011–2012

60 (51–65)
683 (468–1635)

78 (74–82)
1151 (611–2638)
58 (48–64)
933 (597–1997)
77 (73–83)
808 (531–2251)
61 (52–65)
808 (504–1707)
78 (74–82)
911 (531–2473)

<70 years

Huntingdonshire

<70 years
≥70 years

East Cambridge and Fenland

<70 years

60 (51–65)
819 (5061–860)
Age, year
Inpatient payment, £
2008–2009

Table 2

Distribution of age and inpatient payment among people with type 2 diabetes by region and year

≥70 years

Great Cambridge

≥70 years

Open Access
Whether our findings are due to a unique set of circumstances or expected as part of a three-compartment model
(primary care, intermediate care and secondary care) is
unclear, but there are indications that the circumstances
are not special. There are calls for more integration and
less fragmentation in healthcare,22 yet the evidence on
what works in England is limited.23 24 The latest changes
in commissioning in the English NHS, with emphasis on
the need to consider ‘Any qualified Provider’ in service
delivery, and associated market procurement approaches,
could well impair the quality of diabetes care while
increasing overall cost, if the experience here is reproduced elsewhere.
Similarly, as a ‘natural experiment’, it was not possible
to measure the impact of integrated care on inpatient
payments at an individual level. Instead, we estimated
the proportion of the population showing ‘health gain’
(reduced inpatient payments) from the integrated care
intervention by using the distribution curve of inpatient
payment. Although the method was within the conceptual
framework proposed by Sarkardi, some modifications to
the methodology were made to overcome methodological drawbacks, for example, requiring the same SD for
two Gaussian curves: something unlikely to occur in real
scenarios. We believe this revised method would be more
applicable to evaluate the ‘health gain’ for interventions
at a population level.
There are limitations to our study. This was not a
randomised trial, so any changes could be due to secular
trends, although we do compare with the two other areas
in Cambridgeshire. The data depended on the completeness of the coding of diabetes, and there being no systematic change in coding over this time period. We found that
at least one provider had high diabetes ascertainment.10
Data access restrictions prevented adjustment for some
important covariables. As the data used was record based
rather than individual based, repeat inpatient records
were unable to be linked; however, the record-based data
still provide a range of plausible estimations. Moreover,
within a relatively fixed diabetes population served by a
local ‘closed’ inpatient care and tariff system, the likelihood for patients having a second hospital admission
would still be relatively low (although higher than those
without diabetes).10 In other words, inpatient payments at
two time points are considered completely independent
of each other. We acknowledge that this current analysis
still yields findings subject to confounding bias unable
to be measured in this study. The ‘impact’ observed in
our study may therefore only reflect measured changes
in the DICI and ‘control’ regions, respectively, rather
than due to the DICI itself, as the DICI care model was
not randomly assigned. As a result of data access restrictions, it is not possible in this study to identify those with
multiple admissions (and payments) that would provide
‘redundant information’. The application of bootstrapping ignoring such redundant information might lead
to a misapplication of Sarkadi’s tool and might inadvertently increase the false-positive rate: something to be
Yu D, et al. BMJ Open 2017;7:e015816. doi:10.1136/bmjopen-2017-015816
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Figure 1 Using the normal (Gaussian) curve to demonstrate the distribution of inpatient payment in people with type 2
diabetes and possible effects of an integrated care on the curve.The differences between the respective areas under the curve
are shaded. Health gains for participants with lower inpatient payment. Left top: East Cambridge and Fenland, <70 years; right
top: East Cambridge and Fenland, ≥70 years. Left middle: Great Cambridge,<70 years; right middle: Great Cambridge, ≥70
years. Left bottom: Huntingdonshire, <70 years; right bottom: Huntingdonshire, ≥70 years.

taken into consideration when interpreting the findings
in this study. There might be other potential unidentified
confounders in this study and evaluation seeking other
confounding factors would be possible in future studies
with more variables in the dataset including a way to identify those confounders.

In conclusion, we have applied a modified novel
strategy to measure ‘health gain’ associated with an integrated care intervention at a population level. We found
that there were no differences in inpatient payments. Our
findings suggest that irrespective of the ideal principles
behind integration, linking multiple health providers to

Table 3 The estimated absolute ‘health gain (impact)’ after the intervention by age and region: estimation based on normal
distribution of log-transferred inpatient payment data
Impact, %

95% CI, %

P value (bootstrapping)

East Cambridge and Fenland

<70 years
≥70 years

7.69
2.05

(5.89 to 9.74)
(0.72 to 4.13)

0
0.044796

Huntingdonshire

<70 years

6.90

(5.63 to 8.68)

0

≥70 years

4.62

(2.22 to 7.23)

0.001300

<70 years
≥70 years

7.59
2.49

(5.63 to 9.94)
(1.46 to 4.58)

0
0.037096

Greater Cambridge

The health gain (impact) was defined as percentage of people with type 2 diabetes and hospital admission having reduced inpatient payment
after the integrated care at population level.
Yu D, et al. BMJ Open 2017;7:e015816. doi:10.1136/bmjopen-2017-015816
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deliver population-based diabetes care is complex and
improvements in health outcomes remain difficult to
achieve.
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